TERT and urinary bladder cancer: This sort of study was recently conducted by Hosen et al. who investigated the potential of urinary TERT promoter mutations as early detection biomarkers for bladder cancer in asymptomatic individuals in a case-control study nested within a longitudinal population-based prospective cohort of 50,045 Iranian individuals (the Golestan Cohort Study).